All Stories

  1. Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis

    Article • Expert Opinion on Investigational Drugs, June 2019, Taylor & Francis

    Andrea Becciolini, Ennio Giulio Favalli

  2. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection

    Article • Drug Design Development and Therapy, December 2018, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  3. The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future

    Article • BioMed Research International, October 2018, Hindawi Publishing Corporation

    Andrea Becciolini, Ennio Giulio Favalli

  4. Sarilumab: patient-reported outcomes in rheumatoid arthritis

    Article • Patient Related Outcome Measures, August 2018, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  5. The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry

    Article • Drug Design Development and Therapy, May 2018, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  6. A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability

    Article • Drug Design Development and Therapy, June 2017, Dove Medical Press

    Andrea Becciolini, elena agape, Ennio Giulio Favalli

  7. Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis

    Article • Arthritis Care & Research, May 2017, Wiley

    Andrea Becciolini

  8. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis

    Article • Drug Design Development and Therapy, May 2017, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  9. Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date

    Article • Drug Design Development and Therapy, January 2017, Dove Medical Press

    Andrea Becciolini, Ennio Giulio Favalli

  10. The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical Setting

    Article • The Journal of Rheumatology, December 2016, The Journal of Rheumatology

    Andrea Becciolini

  11. The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry

    Article • Journal of International Medical Research, September 2016, SAGE Publications

    Andrea Becciolini

  12. FRI0173 Role of Methotrexate as Combination Therapy with Adalimumab and Etanercept in Rheumatoid Arthritis: Retrospective Analysis from A Local Registry

    Article • Annals of the Rheumatic Diseases, June 2016, BMJ

    Andrea Becciolini

  13. FRI0214 Six-Year Retention Rate of Abatacept in Rheumatoid Arthritis: A Multicentric Retrospective Analysis

    Article • Annals of the Rheumatic Diseases, June 2016, BMJ

    Andrea Becciolini

  14. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

    Article • Seminars in Arthritis and Rheumatism, April 2016, Elsevier

    Andrea Becciolini

  15. Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry

    Article • Arthritis Care & Research, March 2016, Wiley

    Andrea Becciolini

  16. Comment on: Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study: reply

    Article • Rheumatology, September 2015, Oxford University Press (OUP)

    Andrea Becciolini

  17. Structural integrity versus radiographic progression in rheumatoid arthritis: Figure 1

    Article • RMD Open, August 2015, BMJ

    Andrea Becciolini

  18. FRI0497 Drug Retention and Pattern of Discontinuation of the First-Line Anti-TNF Drug in a Large Cohort of Patients with Adult or Juvenile-Onset Inflammatory Arthritides

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Andrea Becciolini

  19. FRI0111 Change Over Time in the Pattern of Clinical Response to First-Line Biologic Drugs: Observational Data from a Local Registry

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Andrea Becciolini

  20. Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study

    Article • Rheumatology, May 2015, Oxford University Press (OUP)

    Andrea Becciolini

  21. Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry: Table 1

    Article • Annals of the Rheumatic Diseases, October 2014, BMJ

    Andrea Becciolini

  22. SAT0524 Predictors of A Clinical Response to Bisphosphonates Treatment in Patients with Complex Regional Pain Syndrome Type I

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Andrea Becciolini

  23. Bone erosions in rheumatoid arthritis: ultrasound findings in the early stage of the disease

    Article • Rheumatology, February 2014, Oxford University Press (OUP)

    Andrea Becciolini

  24. Clinical and serological features of juvenile systemic lupus erythematosus in an italian tertiary centre of pediatric rheumatology

    Article • Pediatric Rheumatology, January 2014, Springer Science + Business Media

    Andrea Becciolini

  25. SAT0413 Inter-reader reliability in the assessment of nailfold capillary abnormalities: A pilot study about an intensive videocapillaroscopy training programme

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Andrea Becciolini

  26. THU0432 Bone erosions in rheumatoid arthritis: Ultrasound findings in the early stage of the disease

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Andrea Becciolini

  27. SAT0214 Reliability and Validity of the Italian Version of the Ucla-Scleroderma Clinical Trial Consortium-Gastrointestinal Tract Instrument in Patients with Systemic Sclerosis

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Andrea Becciolini, Dr Roberta Gualtierotti

  28. Interreader Reliability in Assessment of Nailfold Capillary Abnormalities by Beginners: Pilot Study of an Intensive Videocapillaroscopy Training Program

    Article • The Journal of Rheumatology, April 2012, The Journal of Rheumatology

    Andrea Becciolini

  29. Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab

    Article • Reumatismo, June 2011, PAGEPress Publications

    Andrea Becciolini

  30. The ultrasound assessment of the psoriatic arthritis: from joint to skin

    Article • Reumatismo, June 2011, PAGEPress Publications

    Andrea Becciolini

  31. Sonographic subclinical entheseal involvement in dialysis patients

    Article • Clinical Rheumatology, February 2011, Springer Science + Business Media

    Andrea Becciolini